
|Videos|May 7, 2015
How Biosimilar Drug Approvals Provide Opportunities for Pharmacists
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
Advertisement
Fred Eckel, RPh, MS, Editor-in-Chief of Pharmacy Times, reflects on how pharmacists will be affected by FDA approvals of biosimilars.
This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
Up to 5 Cups of Coffee Daily Safe—and Benficial—for Most Adults
3
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
4
Could VER-01 Redefine the Role of Cannabis in Chronic Pain Care?
5





































































































